GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 915 filers reported holding GLAXOSMITHKLINE PLC in Q1 2022. The put-call ratio across all filers is 0.61 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $9,207,000 | -0.1% | 211,500 | 0.0% | 0.46% | +20.6% |
| Q1 2022 | $9,213,000 | -1.2% | 211,500 | 0.0% | 0.38% | +3.8% |
| Q4 2021 | $9,327,000 | -6.7% | 211,500 | -19.1% | 0.37% | -15.6% |
| Q3 2021 | $9,992,000 | -6.6% | 261,500 | -2.7% | 0.44% | -5.0% |
| Q2 2021 | $10,701,000 | +11.6% | 268,730 | 0.0% | 0.46% | +4.1% |
| Q1 2021 | $9,591,000 | -3.0% | 268,730 | 0.0% | 0.44% | -10.5% |
| Q4 2020 | $9,889,000 | -2.2% | 268,730 | 0.0% | 0.49% | -13.3% |
| Q3 2020 | $10,115,000 | -7.7% | 268,730 | 0.0% | 0.57% | -15.2% |
| Q2 2020 | $10,961,000 | +7.7% | 268,730 | 0.0% | 0.67% | -10.8% |
| Q1 2020 | $10,182,000 | -19.4% | 268,730 | 0.0% | 0.75% | +2.7% |
| Q4 2019 | $12,628,000 | +10.1% | 268,730 | 0.0% | 0.73% | +1.7% |
| Q3 2019 | $11,469,000 | +18.1% | 268,730 | +10.7% | 0.72% | +4.2% |
| Q2 2019 | $9,714,000 | -13.5% | 242,730 | -9.7% | 0.69% | -11.6% |
| Q1 2019 | $11,230,000 | +92.4% | 268,730 | +76.0% | 0.78% | -11.2% |
| Q4 2018 | $5,836,000 | -4.9% | 152,730 | 0.0% | 0.88% | +13.1% |
| Q3 2018 | $6,135,000 | -0.4% | 152,730 | 0.0% | 0.78% | -7.4% |
| Q2 2018 | $6,157,000 | +3.2% | 152,730 | 0.0% | 0.84% | -0.6% |
| Q1 2018 | $5,967,000 | +10.2% | 152,730 | 0.0% | 0.85% | +10.0% |
| Q4 2017 | $5,417,000 | -12.6% | 152,730 | 0.0% | 0.77% | -17.7% |
| Q3 2017 | $6,201,000 | -5.8% | 152,730 | 0.0% | 0.94% | -8.8% |
| Q2 2017 | $6,586,000 | +2.3% | 152,730 | 0.0% | 1.03% | -0.5% |
| Q1 2017 | $6,439,000 | +9.5% | 152,730 | 0.0% | 1.03% | +2.6% |
| Q4 2016 | $5,882,000 | -10.7% | 152,730 | 0.0% | 1.00% | -12.2% |
| Q3 2016 | $6,587,000 | -0.5% | 152,730 | 0.0% | 1.14% | -6.0% |
| Q2 2016 | $6,619,000 | +6.9% | 152,730 | 0.0% | 1.22% | +4.3% |
| Q1 2016 | $6,193,000 | +0.5% | 152,730 | 0.0% | 1.17% | +1.6% |
| Q4 2015 | $6,163,000 | +5.0% | 152,730 | 0.0% | 1.15% | -0.8% |
| Q3 2015 | $5,872,000 | -7.7% | 152,730 | 0.0% | 1.16% | +1.2% |
| Q2 2015 | $6,361,000 | -9.7% | 152,730 | 0.0% | 1.14% | -11.0% |
| Q1 2015 | $7,048,000 | +8.0% | 152,730 | 0.0% | 1.29% | +5.0% |
| Q4 2014 | $6,528,000 | -7.0% | 152,730 | 0.0% | 1.22% | -1.1% |
| Q3 2014 | $7,021,000 | -14.0% | 152,730 | 0.0% | 1.24% | -20.6% |
| Q2 2014 | $8,168,000 | +0.1% | 152,730 | 0.0% | 1.56% | -3.8% |
| Q1 2014 | $8,160,000 | +0.1% | 152,730 | 0.0% | 1.62% | +0.1% |
| Q4 2013 | $8,154,000 | +6.4% | 152,730 | 0.0% | 1.62% | -3.1% |
| Q3 2013 | $7,662,000 | +0.4% | 152,730 | 0.0% | 1.67% | -5.8% |
| Q2 2013 | $7,632,000 | – | 152,730 | – | 1.78% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JTC Employer Solutions Trustee Ltd | 6,324,319 | $241,621,000 | 32.36% |
| Black Creek Investment Management Inc. | 10,329,349 | $394,684,000 | 11.46% |
| Healthcare Value Capital, LLC | 100,000 | $3,821,000 | 7.54% |
| KAHN BROTHERS GROUP INC | 1,353,358 | $51,711,809,000 | 7.28% |
| EQUITY INVESTMENT CORP | 2,924,326 | $111,738,000 | 4.28% |
| Eversept Partners, LP | 1,503,700 | $57,456,377 | 3.99% |
| NKCFO LLC | 269,500 | $10,298,000 | 3.45% |
| Robinson Value Management, Ltd. | 96,990 | $3,706,000 | 3.31% |
| Keystone Financial Planning, Inc. | 237,691 | $9,082,000 | 3.30% |
| CLIFFORD CAPITAL PARTNERS LLC | 93,485 | $3,572,000 | 3.27% |